HYPD · Hyperion Defi, Inc.

These shares were withheld to satisfy tax withholding obligations incurred upon the vesting and settlement of a portion of a previously reported grant of restricted stock units held by the Reporting Person.

Represents restricted stock units that fully vest on the earlier of June 30, 2027 and the date of the Issuer's 2027 annual meeting of stockholders; provided, however, that such awards shall vest immediately in full (a) upon the date on which a Corporate Transaction (as defined in the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan) has occurred, or (b) the date on which the Reporting Person's service on the Issuer's Board of Directors (the "Board") concludes for any reason other than a self-initiated decision by such Reporting Person to step down from the Board.

Represents restricted stock units that fully vest on the earlier of June 30, 2027 and the date of the Issuer's 2027 annual meeting of stockholders; provided, however, that such awards shall vest immediately in full (a) upon the date on which a Corporate Transaction (as defined in the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan) has occurred, or (b) the date on which the Reporting Person's service on the Issuer's Board of Directors (the "Board") concludes for any reason other than a self-initiated decision by such Reporting Person to step down from the Board.

Represents restricted stock units that fully vest on the earlier of June 30, 2027 and the date of the Issuer's 2027 annual meeting of stockholders; provided, however, that such awards shall vest immediately in full (a) upon the date on which a Corporate Transaction (as defined in the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan) has occurred, or (b) the date on which the Reporting Person's service on the Issuer's Board of Directors (the "Board") concludes for any reason other than a self-initiated decision by such Reporting Person to step down from the Board.

Represents restricted stock units that fully vest on the earlier of June 30, 2027 and the date of the Issuer's 2027 annual meeting of stockholders; provided, however, that such awards shall vest immediately in full (a) upon the date on which a Corporate Transaction (as defined in the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan) has occurred, or (b) the date on which the Reporting Person's service on the Issuer's Board of Directors (the "Board") concludes for any reason other than a self-initiated decision by such Reporting Person to step down from the Board.

These shares were withheld to satisfy tax withholding obligations incurred upon the vesting and settlement of a portion of a previously reported grant of restricted stock units held by the Reporting Person.

These shares were withheld to satisfy tax withholding obligations incurred upon the vesting and settlement of a portion of a previously reported grant of restricted stock units held by the Reporting Person

Represents restricted stock units ("RSUs") that vest as follows: (1) 37,500 RSUs shall vest on January 12, 2027 and (2) 37,500 RSUs shall vest in equal installments of 9,375 RSUs beginning three months after January 12, 2027 and continuing every three months thereafter until fully vested, subject to the Reporting Person's continued employment with the Company through each such vesting date.

Represents the volume-weighted average purchase price of several purchases made on the open market at prices ranging from $3.54 to $3.65 per share.

These shares were withheld to satisfy tax withholding obligations incurred upon the vesting and settlement of a portion of a previously reported grant of restricted stock units held by the Reporting Person.

Represents the volume-weighted average purchase price of several purchases made on the open market at prices ranging from $3.54 to $3.65 per share

Represents the volume-weighted average purchase price of several purchases made on the open market at prices ranging from $3.78 to $3.93 per share.

Represents the volume-weighted average purchase price of several purchases made on the open market at prices ranging from $3.78 to $3.93 per share.

Represents the volume-weighted average purchase price of several purchases made on the open market at prices ranging from $3.04 to $3.22 per share.

Represents the volume-weighted average purchase price of several purchases made on the open market at prices ranging from $3.04 to $3.22 per share.

Represents the volume-weighted average purchase price of several purchases made on the open market at prices ranging from $2.98 to $3.1329 per share.

Represents the volume-weighted average purchase price of several purchases made on the open market at prices ranging from $2.97 to $3.10 per share.

Represents restricted stock units ("RSUs") that vest as follows: (1) 50,000 RSUs shall vest on March 29, 2026 and (2) 50,000 RSUs shall vest on September 29, 2026, subject to the Grantee's continued employment with the Company through each such vesting date.

Represents restricted stock units ("RSUs") that vest as follows: (1) 100,000 RSUs shall vest upon the Company achieving a market capitalization of one hundred fifty million dollars ($150,000,000) and (2) 100,000 RSUs shall vest upon the Company achieving a market capitalization of five hundred million dollars ($500,000,000) (the "Market Cap Milestones"), with the Market Cap Milestones to be considered achieved if the applicable threshold is achieved on ten (10) trading days out of a rolling thirty (30) day period, subject to the Grantee's continued employment with the Company through each such vesting date.

Represents restricted stock units ("RSUs") that vest as follows: (1) 25,000 RSUs shall vest on March 31, 2026; (2) 12,500 RSUs shall vest on August 16, 2026; and (3) 12,500 RSUs shall vest on November 16, 2026; provided, however, that such awards shall vest immediately and in full upon a change in control of the Company or termination of the director's board service for other than a voluntary resignation.

These grants shall vest as follows: (i) 500,000 shares shall vest upon the Issuer achieving a market capitalization of $150,000,000 and (ii) 500,000 shares shall vest upon the Issuer achieving a market capitalization of $500,000,000.

Represents restricted stock units ("RSUs") that vest as follows: (1) 25,000 RSUs shall vest on December 15, 2025; (2) 12,500 RSUs shall vest on May 26, 2026; and (3) 12,500 RSUs shall vest on August 16, 2026; provided, however, that such awards shall vest immediately in full upon the date on which a Corporate Transaction (as defined in the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan) has occurred, or (b) the date on which the Reporting Person's service on the Issuer's Board of Directors (the "Board") concludes for any reason other than a self-initiated decision by such Reporting Person to step down from the Board.

Represents restricted stock units ("RSUs") that vest as follows: (1) 25,000 RSUs shall vest on December 15, 2025; (2) 12,500 RSUs shall vest on May 26, 2026; and (3) 12,500 RSUs shall vest on August 16, 2026; provided, however, that such awards shall vest immediately in full upon the date on which a Corporate Transaction (as defined in the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan) has occurred, or (b) the date on which the Reporting Person's service on the Issuer's Board of Directors (the "Board") concludes for any reason other than a self-initiated decision by such Reporting Person to step down from the Board.

Represents restricted stock units ("RSUs") that vest as follows: (1) 25,000 RSUs shall vest on December 15, 2025; (2) 12,500 RSUs shall vest on May 26, 2026; and (3) 12,500 RSUs shall vest on August 16, 2026; provided, however, that such awards shall vest immediately in full upon the date on which a Corporate Transaction (as defined in the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan) has occurred, or (b) the date on which the Reporting Person's service on the Issuer's Board of Directors (the "Board") concludes for any reason other than a self-initiated decision by such Reporting Person to step down from the Board.

These grants vested in full immediately effective with Mr. Jung's start date with the Company on June 17, 2025.

These grants vested in full upon the closing of the Company's private placement financing on June 20, 2025.

These grants vested in full upon the closing of the Company's private placement financing on June 20, 2025.

These grants vested in full upon the closing of the Company's private placement financing on June 20, 2025.

These grants vested in full upon the closing of the Company's private placement financing on June 20, 2025.

Represents restricted stock units that will fully vest upon the closing of the Issuer's proposed business combination with Betaliq, Inc. Vesting is subject to the Reporting Person's continued service to the Issuer.

On January 31, 2025, the Issuer effected a reverse stock split of its common stock at a ratio of 1-for-80 (the "Reverse Split"). The Reporting Person's ownership of the Issuer's securities has been adjusted to reflect the impact of the Reverse Split.

Represents restricted stock units that will fully vest on the earliest of the following events: (i) one year from the date of issuance, (ii) a change in control of the Issuer, and (iii) the date on which the Reporting Person's employment with the Issuer is terminated, except in the event of a voluntary resignation by the Reporting Person. Vesting is subject to the Reporting Person's continued service to the Issuer.

On January 31, 2025, the Issuer effected a reverse stock split of its common stock at a ratio of 1-for-80 (the "Reverse Split"). The Reporting Person's ownership of the Issuer's securities has been adjusted to reflect the impact of the Reverse Split.

Represents restricted stock units that will fully vest upon the closing of the Issuer's proposed business combination with Betaliq, Inc. Vesting is subject to the Reporting Person's continued service to the Issuer.

On January 31, 2025, the Issuer effected a reverse stock split of its common stock at a ratio of 1-for-80 (the "Reverse Split"). The Reporting Person's ownership of the Issuer's securities has been adjusted to reflect the impact of the Reverse Split.

Represents restricted stock units that will fully vest upon the closing of the Issuer's proposed business combination with Betaliq, Inc. Vesting is subject to the Reporting Person's continued service to the Issuer.

On January 31, 2025, the Issuer effected a reverse stock split of its common stock at a ratio of 1-for-80 (the "Reverse Split"). The Reporting Person's ownership of the Issuer's securities has been adjusted to reflect the impact of the Reverse Split.

Represents restricted stock units that will fully vest upon the closing of the Issuer's proposed business combination with Betaliq, Inc. Vesting is subject to the Reporting Person's continued service to the Issuer.

On January 31, 2025, the Issuer effected a reverse stock split of its common stock at a ratio of 1-for-80 (the "Reverse Split"). The Reporting Person's ownership of the Issuer's securities has been adjusted to reflect the impact of the Reverse Split.

Represents restricted stock units that will fully vest upon the closing of the Issuer's proposed business combination with Betaliq, Inc. Vesting is subject to the Reporting Person's continued service to the Issuer.

On January 31, 2025, the Issuer effected a reverse stock split of its common stock at a ratio of 1-for-80 (the "Reverse Split"). The Reporting Person's ownership of the Issuer's securities has been adjusted to reflect the impact of the Reverse Split.

Represents restricted stock units that will fully vest upon the closing of the Issuer's proposed business combination with Betaliq, Inc. Vesting is subject to the Reporting Person's continued service to the Issuer.

On January 31, 2025, the Issuer effected a reverse stock split of its common stock at a ratio of 1-for-80 (the "Reverse Split"). The Reporting Person's ownership of the Issuer's securities has been adjusted to reflect the impact of the Reverse Split.

On February 21, 2025, ACM II, as "Agent", and AVOF and AVOF II, as "Lenders", and Issuer entered into a Second Amendment to Supplement to Loan and Security Agreement dated November 22, 2022 (collectively, as amended and supplemented, the "Agreement"), pursuant to which Lenders have the right in their discretion at any time on or after April 1, 2025, to convert an aggregate amount of up to $10,000,000 of the aggregate principal amount of the outstanding Growth Capital Loans (as defined in the Agreement) into common stock of Issuer at a per share price of $1.68.

See footnote 3.

Not applicable.

Reporting Persons have not converted any debt to date.

Represents grant of stock options, which vest in equal quarterly installments on the first, second, third and fourth anniversaries of the date of grant, such that the stock options will be fully vested and exercisable on August 30, 2028.

The purchase price per share for the common stock set forth above is the combined purchase price for each share of common stock, together with a warrant to purchase one share of common stock issued pursuant to a securities stock purchase agreement among the Company, the Reporting Person and other purchasers (the "Securities Purchase Agreement")

In connection with the Securities Purchase Agreement, the Reporting Person also received a total of 3,264,931 warrants to purchase common stock at an exercise price of $0.69 per share (consisting of 1,515,151 warrants issued together with the shares purchased and an additional 1,749,780 warrants) and had the exercise price of all of his previously issued warrants (consisting of 677,430 warrants) reduced to $0.69 per share and the expiration date thereof extended to January 1, 2030.

The purchase price per share for the common stock set forth above is the combined purchase price for each share of common stock, together with a warrant to purchase one share of common stock issued pursuant to a securities stock purchase agreement among the Company, the Reporting Person and other purchasers (the "Securities Purchase Agreement")

In connection with the Securities Purchase Agreement, the Reporting Person also received a total of 3,264,931 warrants to purchase common stock at an exercise price of $0.69 per share (consisting of 1,515,151 warrants issued together with the shares purchased and an additional 1,749,780 warrants) and had the exercise price of all of his previously issued warrants (consisting of 677,430 warrants) reduced to $0.69 per share and the expiration date thereof extended to January 1, 2030.

Includes 3,942,361 shares of common stock issuable upon exercise of all warrants currently owned by the Reporting Person

The option becomes exercisable on the earlier of June 12, 2025 or the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control.

Represents restricted stock units that fully vest on the earlier of June 12, 2025 or the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control.

Represents restricted stock units that fully vest on the earlier of June 12, 2025 or the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control.